About
Stephen M Perry, Chief Executive Officer and Founder of Kymanox, is an accomplished life sciences business leader with nearly three decades of experience. Mr Perry has participated in the US FDA commercial approval of over two dozen unique drugs, devices, biologics and combination products. In 2004, he created Kymanox, a professional services firm specialising in the development and commercialisation of modern medicines. Prior to this, he held roles at M+W Group, Abbott Laboratories, FujiFilm Diosynth Biotechnologies and Human Genome Sciences. He holds a Bachelor’s degree in chemical engineering from the University of Notre Dame (IN, US).